What is a PBM, and why is this insurance middleman so harmful to your treatment access?
視聴回数 389 回
0
0
Find out from real patients what life with chronic disease feels like. The invisible pain, the insurance battles, and the hidden full-time job "being sick" entails, can feel like too much at times, and it is a weight you shouldn't have to carry alone.
What are pharmacy benefit managers or PBMs?
PBMs serve as the “middlemen” between drug manufacturers and insurance companies. These companies, which are often owned by insurers, claim to negotiate drug prices in order to lower healthcare costs. In reality, PBMs serve as the gatekeepers to insurance companies’ formularies (list of drugs the insurer will cover) and require drug manufacturers to offer rebates in exchange for having their drugs listed. These rebates perversely incentivize PBMs to select drugs based on their rebates rather than patient needs. This system keeps drug prices high for patients, while insurers and their PBMs pocket rebates and profit.
Are you an infusion patient that wants to help shed light on the chronic disease journey? Reach out to the Infusion Access Foundation team so we can hear your story and help you find the right pathway for you to be really heard.
Infusion Access Foundation (IAF) is a community of patients united to protect access to treatments that you get at a clinic, such as infusions and injections. We support each other across all diseases and advocate with one voice that reaches policy makers.
Want to make your voice heard? Go to https://patientaccess.org/advocacy/pbms
What are pharmacy benefit managers or PBMs?
PBMs serve as the “middlemen” between drug manufacturers and insurance companies. These companies, which are often owned by insurers, claim to negotiate drug prices in order to lower healthcare costs. In reality, PBMs serve as the gatekeepers to insurance companies’ formularies (list of drugs the insurer will cover) and require drug manufacturers to offer rebates in exchange for having their drugs listed. These rebates perversely incentivize PBMs to select drugs based on their rebates rather than patient needs. This system keeps drug prices high for patients, while insurers and their PBMs pocket rebates and profit.
Are you an infusion patient that wants to help shed light on the chronic disease journey? Reach out to the Infusion Access Foundation team so we can hear your story and help you find the right pathway for you to be really heard.
Infusion Access Foundation (IAF) is a community of patients united to protect access to treatments that you get at a clinic, such as infusions and injections. We support each other across all diseases and advocate with one voice that reaches policy makers.
Want to make your voice heard? Go to https://patientaccess.org/advocacy/pbms
